IMMUNOLOGICAL PROFILES OF CYTOTOXIC CELLS IS ASSOCIATED WITH TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA LS Binelli; LC Palma; CAB Garcia; LO Marani; M Medeiros; AG Carvalho; PS Scheucher; JLS Schiavinato; PMM Garibaldi; RS Welner; FA Castro; KBB Pagnano; LL Figueiredo-Pontes;

IMMUNE MATURATION AND CHECKPOINT DYNAMICS DURING TYROSINE KINASE INHIBITOR DOSE REDUCTION PREDICT RELAPSE RISK IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDERGOING TREATMENT DISCONTINUATION LS Binelli; LC Palma; CAB Garcia; M Medeiros; AG de Carvalho; BL Adjafre; LO Marani; PS Scheucher; JLS Schiavinato; PMM Garibaldi; RL Pacca; FS Seguro; RS Tavares; LL Almeida; RS Welner; KBB Pagnano; LL de Figueiredo-Pontes;

IMMUNOPHENOTYPIC SIGNATURE OF LEUKEMIA ARREST STAGE IS ASSOCIATED WITH NPM1/FLT3 MUTATIONAL PROFILE AND PROGNOSIS IN ACUTE MYELOID LEUKEMIA AG Carvalho; LO Marani; CAB Garcia; M Medeiros; LS Binelli; AFO Costa; EVB Ferreira; JLS Schiavinato; PS Scheucher; LL Figueiredo-Pontes;